Oncology Business Management | Specialty

FDA Panel Narrowly Supports New CRC Blood Test

March 27th 2014

The blood-based colorectal cancer (CRC) screening test Epi proColon passed the scrutiny of the FDA's Molecular and Clinical Genetics advisory panel in a close 5-4 vote with 1 abstention in support of the claim that the test's benefits outweigh its risks

Tackling Patient Recruitment Challenges in Clinical Trials

March 26th 2014

Patients fear being a "guinea pig" or receiving a placebo, healthcare providers do not have time to keep up with all of the clinical trial information or talk with patients in depth, conducting clinical trials is very expensive for healthcare systems, and funding continues to decline for research.

AMA's Guide to Medicare Payment System Now Available

March 26th 2014

Practice managers who need to understand the ins and outs of Medicare's resource-based relative value scale (RBRVS) can purchase an updated physician guide from the American Medical Association.

Some Docs Hesitant to Embrace Genomic Tests That Identify Tumor Changes

March 25th 2014

A physician's confidence level in his genomic knowledge plays a significant role in attitudes towards genomic tests, especially in tests that look for changes in DNA that are taken from patients' tumor samples

Gilead Sciences Moves Ahead on Idelalisib Filings

March 24th 2014

Founded in 1987, Gilead Sciences made a name for itself in 1996, when it launched Vistide, a treatment for cytomegalovirus retinitis in patients with AIDS.

ICD-10 Is Biggest Healthcare IT Story for 2014

March 24th 2014

Small practices face all the difficulties of health IT implementation without the benefit of big budgets and numerous staff to diffuse the burdens, according to EHRIntelligence.com.

Patients Coping With Insomnia May Benefit from Behavioral Interventions

March 20th 2014

Cognitive behavioral therapy for insomnia (CBT-I) and mindfulness-based stress reduction (MBSR) can improve sleep for patients with cancer, but CBT-I continues to be the best nonpharmacologic option

Dr. Oh on a Biomarker Development Trial in mCRPC

March 20th 2014

William K. Oh, MD, professor of medicine, hematology and medical oncology, urology, The Mount Sinai Hospital, discusses a biomarker development trial in metastatic castrate-resistant prostate cancer (mCRPC).

Despite a Low-Tier Ranking, Patients Remain Loyal to Their Personal Doc

March 20th 2014

Patients were no more likely to switch away from lower-tiered physicians than higher-tiered physicians within their health plan, especially if the physician was considered the patient's personal doctor

Folkman's Legacy of Bold and Creative Thinking Endures

March 19th 2014

During the course of a 74-year life cut short by his sudden death in 2008, Folkman changed the world repeatedly with bold ideas that ranged from implantable pacemakers and subcutaneous birth control to an entirely new field of medical study: how diseases like cancer recruit blood vessels from the body via angiogenesis.

Conclusion: Optimizing the Treatment of RCC

March 19th 2014

RCC Journal Highlights and Implications for Clinical Practice

March 19th 2014

Novel Therapies in Renal Cell Carcinoma

March 19th 2014

Evolving Role of Genomic Testing in RCC

March 19th 2014

Case Study: Utilizing Multiple Therapies in mRCC

March 19th 2014

Drug Holidays in Renal Cell Carcinoma

March 19th 2014

Case Study: Observation in Metastatic RCC

March 19th 2014

Case Study: Treating Progressive Renal Cell Carcinoma

March 19th 2014

Second-Line Angiogenesis Inhibition in mRCC

March 19th 2014

Second-Line Treatment of Metastatic Renal Cell Carcinoma

March 19th 2014